The JPMorgan BetaBuilders U.S. Small Cap Equity ETF (BBSC), launched on November 16, 2020 and sponsored by J.P. Morgan, is a passively managed fund that aims to match the Small Cap Value segment of the U.S. equity market, with more than $727.94 million in assets. Its annual operating expense is 0.09%, and its 12-month trailing dividend yield is 1.07%. Information Technology is the largest sector at about 17.6% of the portfolio, while the top 10 holdings account for about 5.03% of total assets across roughly 853 holdings. As of 10/23/2026, the ETF is up about 15.45% year to date and 15.76% over the last year, trading between $69.41 and $93.36 in the past 52 weeks. It has a beta of 1.15 and a three-year standard deviation of 21.23%.
Summary written by Upside AI from the original article. Read the source for full details.
Read the original on Yahoo Finance ↗
Keywords
Open a keyword to see other news on the same topic.
Related tickers and likely impact
JPM
• NeutralJPMorgan Chase
Relevance: low
| Market | US stocks |
|---|---|
| Sector | Financials |
| Industry | Diversified Banks |
| Market cap | $894.6B |
| Close on 10/22/2026 | 336.54 |
| Change that session | +0.40% |
Impact is scored by AI from the headline and may be wrong. It is not investment advice.
Related news
- Small caps are thriving . Aggressive investors may want to consider this ETF
The S&P/TSX Small Cap Index rose 17.7% year-to-date as of Oct. 16, about 25% better than the Composite Index, after small caps lagged large caps over 2014–2023, with annualized returns of 2.9% versus 8.1%. The article says small caps were previously shunned for their volatility, limited analyst coverage and many money-losing firms, but energy, now the top-performing TSX sector this year due to the wars in Ukraine and Iran, has lifted the group. The iShares S&P/TSX SmallCap Index ETF (XCS-T) is up 18.81% year-to-date; it was recommended at $23.90 and closed at $36.09. The fund holds 236 positions, has about $250 million in assets, a 0.6% MER, and a 10-year average annual return of 10.71%. The author considers it suitable for aggressive investors who can tolerate volatility.
- Differences in Fees, Liquidity, and Dividend Yield Highlight This Matchup of Small-Cap ETFs
The article compares two U.S. small-cap ETFs, the JPMorgan BetaBuilders U.S. Small Cap Equity ETF (BBSC) and the Schwab U.S. Small-Cap ETF (SCHA), which both track U.S. small-cap indexes but differ in cost, size and holdings. SCHA has the lower expense ratio at 0.03% versus 0.09% for BBSC, and holds 1,753 positions against BBSC's 849. Over five years, total returns were similar: 37% for SCHA (CAGR 6.5%) and 38% for BBSC (CAGR 6.7%). SCHA's dividend yield of 1.15% is slightly higher than BBSC's 1.09%, and the article says SCHA also offers greater liquidity. Overall, the article concludes SCHA has the edge on fees, income and liquidity.
- J.P. Morgan Projects 10% a Year for Bitcoin: The Bank’s Own Bear Case Points to $25,000
J.P. Morgan Asset Management projects a 10% annual return for Bitcoin over the next decade in its 2027 Long-Term Capital Market Assumptions, published October 19. That is the highest figure in the report's table, ahead of U.S. REITs at 8.2%, U.S. large caps at 7.5%, aggregate bonds at 5.6%, gold at 5.5% and cash at 3.2%. The bank also gives a bull case of 16.6% and a bear case of -11.2% per year, from an $83,000 starting price on September 30, which translate to about $386,000, $215,000 (base) and $25,000 per BTC by 2036. The authors call Bitcoin a speculative asset, say a 10-year forecast is premature, and keep it out of their main portfolio models; one framework based on network adoption gives a base case of -3.2% a year. U.S. spot Bitcoin ETFs took in $23.2 million on Tuesday, and three newly created wallets received 1,090 BTC ($90.38 million) from Wintermute early on Wednesday.
- JPMorgan Puts a Number on Bitcoin for the First Time: 10% a Year, With a Big Caveat
J.P. Morgan Asset Management projected a 10% compound annual return for Bitcoin over the next 10 to 15 years in its 2027 Long-Term Capital Market Assumptions, the first time the report includes the asset. That forecast tops its estimates for U.S. large-cap stocks (7.5%), gold (5.5%) and a 60/40 stock-bond portfolio (7%), but the report puts Bitcoin's annualized volatility at 55%, versus about 17% for gold. The firm still excludes Bitcoin from its main covariance matrices, citing volatility and unstable correlations, and rejected the currency debasement bull case as “wide of the mark.” Bitwise's Matt Hougan welcomed the forecast but argued the 55% volatility assumption is too high, making the return estimate too conservative. Meanwhile, U.S. spot Bitcoin ETFs drew $526.7 million on Monday, trimming October's net outflows to about $88 million.
- JPMorgan Asset Sees Bitcoin Beating Stocks, But With a Catch
JPMorgan Asset Management has included Bitcoin in its long-term capital market assumptions for the first time, with base-case annualized returns of 10% over the next decade. The forecast also assumes annual volatility of 55%, more than three times that of US large-cap stocks, so the firm has not added Bitcoin to its main portfolio models, citing unstable correlations with other assets. The JPMorgan team says it is premature to treat BTC as a diversifier in a balanced portfolio, though that could change if volatility declines and correlations stabilize. About one in ten clients surveyed said their portfolios hold crypto and roughly 17% plan to prioritize it, helped by a more developed regulatory framework. Bitcoin ETF investors who bought near the 2025 peak of just over $126,000 saw their holdings lose as much as 50%.
- JPMorgan eyes $2 trillion as Europe ETF demand builds
Related markets
Latest news
- Micron Just Delivered a Monster Quarter, but the Stock Is Plummeting. The Reason Is Obvious.
Micron (MU) posted record fiscal fourth-quarter results, with revenue of $54.2 billion, up nearly 380% year over year, and EPS of $32.87, and guided to $61.5 billion in revenue for fiscal Q1 2027. Despite this, the stock has fallen roughly 20% since the report and was about 29% below its all-time high as of Oct. 22. The article attributes the sell-off to concerns about the sustainability of AI capital spending, high valuations and whether the memory industry's unusually high profitability will last, while the iShares Semiconductor ETF has declined 15% since the report. The author views the forward P/E of about 7 as modest and believes investors may have already priced in considerable downside risk.
- YYForce Applauds Tesla and Elon Musk on Commencing Manufacturing of Optimus Humanoid Robots
YYForce Inc. (NASDAQ: YFOR) congratulated Tesla and Elon Musk after Tesla said production of its Optimus humanoid robot has begun in Fremont, California, a phase Tesla describes as early ramp. YYForce plans to deploy its first humanoid robot at Novotel Singapore on Stevens in early November 2026 to evaluate hospitality applications, with the scope depending on technical readiness and initial results. The company stresses that this is a separate initiative: the release announces no partnership or endorsement involving Tesla, and the robot to be deployed is not a Tesla Optimus.
- Elon Musk predicts many neoclouds will experience 'guppy-level death'
SpaceX (SPCX) confirmed it has closed a $40 billion finance lease deal for Nvidia (NVDA) AI chips, backed by Apollo. Elon Musk said debt markets have largely stopped lending to neoclouds that rely on revenue to pay for data centers, and that more than 200 neoclouds will see "guppy-level death" through consolidation, with few surviving. The $40 billion deal has not yet priced; Bloomberg reported its debt could price at around 8%, above earlier expectations, while CoreWeave's debt is trading at about 15%. Chamath, an AI bull, also said it will be a consolidation year for a few. The hosts noted Musk's comments may be self-serving, or aimed at talking prices down so he can pick up more computing capacity.
- Moderna Tumbles 7% as Cancer Vaccine Selloff Deepens; BioNTech Falls 3%, Pfizer Holds Steady
Moderna shares fell 7% to $185.74 in morning trading after its personalized melanoma vaccine, intismeran autogene, given with Keytruda, met its primary goal of reducing the risk of recurrence or death, but its effect on distant metastasis was far smaller than an earlier mid-stage study suggested. Detailed late-stage results were released on October 22 ahead of a conference in Madrid. BioNTech fell 3% to $85.65, Merck fell 0.2% to $145.61 and Pfizer fell 0.2% to $29.96, while the iShares Biotechnology ETF rose 0.2% to $208.21. The article notes Moderna's business relies entirely on mRNA medicines, so the vaccine carries a large share of its pipeline value, and says the next step is whether the full dataset supports a regulatory filing.
- HOOD’s prediction markets to add $1.7B to revenue, exceed crypto by 2028: Bernstein
Bernstein raised its revenue estimates for Robinhood Markets (HOOD) for 2026, 2027 and 2028 by 3%, 4% and 3% respectively, and kept its $160 price target unchanged. The firm expects prediction markets to grow from about $650 million this year to $1.7 billion in 2028, surpassing projected crypto-based revenue of $1.6 billion and accounting for roughly 18% of the projected $9.4 billion in total 2028 revenue. Bernstein expects Q3 revenue to rise 13% quarter over quarter to around $1.5 billion, driven by equity, options and event contract volumes and a recovery in crypto trading. HOOD was set to open lower, with premarket trading at $93.60, and is down more than 29% over the past 12 months.
- One Catalyst Could Completely Change the Tesla Stock Story
The article argues that the unsupervised Robotaxi fleet could decide the Tesla stock story, but its economics have not yet shown up in reported results. The 24/7 Wall St. model sets a price target of $404.84, 8.1% above the $374.58 close on October 22, and rates the stock hold because it sees shares trading near fair value. In Q3, revenue of $28.05 billion and EPS of $0.48 beat estimates, but operating income fell 55.79% as R&D rose to $2.76 billion and battery supply limited deliveries to 486,532 vehicles. Free cash flow dropped 61.63% to $1.53 billion, while management expects about $20 billion in capex this year. Traders put 65.5% odds on a SpaceX merger being announced by the end of 2027.
Get the briefing on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the Vietnam stocks and gold briefing at 8:00 and 19:00 (Vietnam time) on trading days, plus a weekly wrap on Saturday morning.